AMDHD2 / CGI-14 antibody
Principal name
AMDHD2 / CGI-14 antibody
Alternative names for AMDHD2 / CGI-14 antibody
Putative N-acetylglucosamine-6-phosphate deacetylase, GlcNAc 6-P deacetylase, Amidohydrolase domain-containing protein 2
Ncbi ID
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of AMDHD2 / CGI-14 antibody
- Kit Component:
- - KN205838G1, AMDHD2 gRNA vector 1 in pCas-Guide vector
- KN205838G2, AMDHD2 gRNA vector 2 in pCas-Guide vector
- KN205838D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of AMDHD2 expression in transfected 293T cell line (H00051005-T01) by AMDHD2 MaxPab polyclonal antibody.Lane 1: CGI-14 transfected lysate(48.29 KDa).Lane 2: Non-transfected lysate.
AMDHD2 MaxPab polyclonal antibody. Western Blot analysis of AMDHD2 expression in SW-13.
Western Blot analysis of AMDHD2 expression in transfected 293T cell line (H00051005-T01) by AMDHD2 MaxPab polyclonal antibody.Lane 1: CGI-14 transfected lysate(48.29 KDa).Lane 2: Non-transfected lysate.
AMDHD2 MaxPab polyclonal antibody. Western Blot analysis of AMDHD2 expression in SW-13.
Predicted cell location: Cytoplasm. Positive control: Human lymphoma and thyroid cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human lymphoma tissue using AMDHD2 antibody at dilution 1/30, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human lymphoma and thyroid cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using AMDHD2 antibody at dilution 1/30, on the right is treated with the fusion protein. (Original magnification:x200)
Predicted cell location: Cytoplasm. Positive control: Human thyroid and liver cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using AMDHD2 antibody at dilution 1/40, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human thyroid and liver cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human liver cancer tissue using AMDHD2 antibody at dilution 1/40, on the right is treated with the fusion protein. (Original magnification:x200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA323952 | AMDHD2 / CGI-14 antibody |
||||||
| Anti-AMDHD2 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA323953 | AMDHD2 / CGI-14 antibody |
||||||
| Anti-AMDHD2 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY414297 | AMDHD2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR205956L2V | Lenti ORF particles, Amdhd2 (GFP-tagged ORF) - Rat amidohydrolase domain containing 2 (Amdhd2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR205956L1V | Lenti ORF particles, Amdhd2 (Myc-DDK-tagged ORF) - Rat amidohydrolase domain containing 2 (Amdhd2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||